FDA
approval
· 2022-11-22
FDA Approved: TIMOLOL MALEATE — Supplemental Application (Sandoz Inc)
Summary
FDA approved a supplemental application for timolol maleate submitted by Sandoz Inc. This action supplements an existing approval for the ophthalmic product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TIMOLOL MALEATE (TIMOLOL MALEATE)